Moment Of Truth For Eight New Drugs In EU
Mix Of Novel Treatments And Generics May Get Approval Recommendation
PTC Therapeutics’ gene therapy, eladocagene exuparvovec, and Sanofi’s enzyme replacement therapy, olipudase alfa, are among the latest products that the European Medicines Agency is considering for potential marketing approval.